China ventures into drug development with new flu vaccine

By Admin
A new Chinese influenza vaccine has been approved by the World Health Organization, according to The Economic Times. The vaccine is the only the second...

A new Chinese influenza vaccine has been approved by the World Health Organization, according to The Economic Times. The vaccine is the only the second Chinese vaccine to be considered “safe and effective.”

RELATED TOPIC: China's health care IT market to reach $4 billion by 2020

In a statement released by the World Health Organization (WHO), the approval of the vaccine—made by Hualan Biological Bacterin Corp.—involved stringent lab tests and a site inspection.

The other vaccine made in China to achieve WHO pre-qualification was a drug against Japanese encephalitis in 2013.

RELATED TOPIC: This is how women and children receive vaccines in the Congo

“WHO prequalification of the Hualan vaccine is another feather in the cap of China’s growing vaccine manufacturing industry,” said Bernhard Schwartlander, WHO representative in China, in a statement.

He added that the development “shows that the country is set to become one of the preeminent vaccine manufacturers globally.”

According to The Economic Times, “Chinese drug makers saw sales growth speed up and margins widen at the start of the year.”

RELATED TOPIC: TOP 10: Emerging trends in alternative medicine

This is a sign that the world’s second-largest pharmaceuticals market may be “rebounding from a crackdown on corruption and high prices.”

This newly approved vaccine is China’s venture into drug development as the country also approved a new polio vaccine in January of this year—one month after local authorities also approved a home-grown Ebola vaccine. 

Let's connect!   

Read the latest edition of Healthcare Global magazine!

[SOURCE: The Economic Times]

Share

Featured Articles

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

CGI is driving efficiency in healthcare. Hear from Helena Jochberger, at Manufacturing Digital LIVE, a free virtual event on Wednesday 6th December 2023

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI

AI & ML

Healthtech platform CoverSelf extends seed round to US$8.2m

Technology & AI